Prelude Therapeutics Inc (PRLD) has 55 open-market insider trades by 18 insiders since 2020. Over the last six months insiders net bought $25.0M. The most active filer is David J. Mauro.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| David P. Bonita | Dir10% Owner | — | 3 | $46.0M | 2026-04-21 |
| Baker Bros. Advisors (GP) LLC via Felix Baker | Dir10% Owner | — | 1 | $30.0M | 2020-09-29 |
| Orbimed Advisors LLC | Dir10% Owner | — | 1 | $12.5M | 2026-04-21 |
| Julian Baker | Dir10% Owner | — | 1 | $10.0M | 2021-01-11 |
| David J. Mauro | — | — | 10 | $5.4M | 2021-10-05 |
| Orbimed Capital LLC | Dir10% Owner | — | 1 | $5.0M | 2023-05-22 |
Dir10% Owner | — | 1 | $2.5M | 2021-01-11 | |
| OrbiMed Capital GP VI LLC | Dir10% Owner | — | 1 | $2.5M | 2021-01-11 |
| Peggy Scherle | CSO | — | 6 | $2.1M | 2021-08-27 |
| Krishna Vaddi | CEO | — | 10 | $1.5M | 2025-03-25 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Orbimed Advisors LLC | Director & 10% Owner | Buy | $12.5M | 2026-04-21 |
| Andrew Combs | — | Buy | $69K | 2025-03-25 |
| Krishna Vaddi | CEO | Buy | $932K | 2025-03-25 |
| Krishna Vaddi | CEO | Buy | $15K | 2025-03-20 |
| Krishna Vaddi | CEO | Buy | $29K | 2025-03-14 |
| Krishna Vaddi | CEO | Buy | $70K | 2025-03-12 |
Companies that share insiders with PRLD, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Krishna Vaddi | CEO | Buy | $6K | 2024-12-31 |
| Krishna Vaddi | CEO | Buy | $12K | 2024-12-30 |
| Andrew Combs | — | Buy | $86K | 2024-12-20 |
| Bryant David Lim | CLO & Interim CFO +1 | Buy | $23K | 2024-12-19 |
| Krishna Vaddi | CEO | Buy | $99K | 2024-12-18 |
| Bryant David Lim | CLO & Corp Sec. | Buy | $13K | 2023-05-24 |
| Krishna Vaddi | CEO | Buy | $10K | 2023-05-24 |
| Krishna Vaddi | CEO | Buy | $133K | 2023-05-23 |
| Laurent Chardonnet | CFO | Buy | $28K | 2023-05-23 |